HLA types in celiac disease patients not carrying the DQA1* 05-DQB1* 02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease K Karell, AS Louka, SJ Moodie, H Ascher, F Clot, L Greco, PJ Ciclitira, ... Human immunology 64 (4), 469-477, 2003 | 842 | 2003 |
FinnGen provides genetic insights from a well-phenotyped isolated population MI Kurki, J Karjalainen, P Palta, TP Sipilä, K Kristiansson, KM Donner, ... Nature 613 (7944), 508-518, 2023 | 786 | 2023 |
Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors T Not, K Horvath, ID Hill, J Partanen, A Hammed, G Magazzu, A Fasano Scandinavian journal of gastroenterology 33 (5), 494-498, 1998 | 494 | 1998 |
Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus G Thomson, WP Robinson, MK Kuhner, S Joe, MJ MacDonald, ... American journal of human genetics 43 (6), 799, 1988 | 458 | 1988 |
Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure K Kaukinen, L Halme, P Collin, M Färkkilä, M Mäki, P Vehmanen, ... Gastroenterology 122 (4), 881-888, 2002 | 381 | 2002 |
HLA-DQ typing in the diagnosis of celiac disease K Kaukinen, J Partanen, M Mäki, P Collin Official journal of the American College of Gastroenterology| ACG 97 (3 …, 2002 | 366 | 2002 |
FinnGen: Unique genetic insights from combining isolated population and national health register data MI Kurki, J Karjalainen, P Palta, TP Sipilä, K Kristiansson, K Donner, ... MedRxiv, 2022.03. 03.22271360, 2022 | 354 | 2022 |
Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits TT Salmi, P Collin, IR Korponay-Szabo, K Laurila, J Partanen, H Huhtala, ... Gut 55 (12), 1746-1753, 2006 | 327 | 2006 |
Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study K Kurppa, P Collin, M Viljamaa, K Haimila, P Saavalainen, J Partanen, ... Gastroenterology 136 (3), 816-823, 2009 | 326 | 2009 |
Secretor genotype (FUT2 gene) is strongly associated with the composition of Bifidobacteria in the human intestine P Wacklin, H Mäkivuokko, N Alakulppi, J Nikkilä, H Tenkanen, J Räbinä, ... PloS one 6 (5), e20113, 2011 | 305 | 2011 |
Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency IR Korponay-Szabó, I Dahlbom, K Laurila, S Koskinen, N Woolley, ... Gut 52 (11), 1567-1571, 2003 | 283 | 2003 |
Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus J Mustonen, J Partanen, M Kanerva, K Pietilä, O Vapalahti, A Pasternack, ... Kidney international 49 (1), 217-221, 1996 | 271 | 1996 |
The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease P Wacklin, K Kaukinen, E Tuovinen, P Collin, K Lindfors, J Partanen, ... Inflammatory bowel diseases 19 (5), 934-941, 2013 | 247 | 2013 |
AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype M Halonen, P Eskelin, AG Myhre, J Perheentupa, ES Husebye, ... The Journal of Clinical Endocrinology & Metabolism 87 (6), 2568-2574, 2002 | 235 | 2002 |
Celiac disease without villous atrophy K Kaukinen, M Mãki, J Partanen, H Sievãnen, P Collin Digestive diseases and sciences 46, 879-887, 2001 | 235 | 2001 |
Celiac disease and markers of celiac disease latency in patients with primary Sjögren’s syndrome S Iltanen, P Collin, M Korpela, K Holm, J Partanen, A Polvi, M Mäki The American journal of gastroenterology 94 (4), 1042-1046, 1999 | 211 | 1999 |
Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease K Kaukinen, M Peräaho, K Lindfors, J Partanen, N Woolley, P Pikkarainen, ... Alimentary pharmacology & therapeutics 25 (10), 1237-1245, 2007 | 202 | 2007 |
Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population J Jääskeläinen, A Levo, R Voutilainen, J Partanen The Journal of Clinical Endocrinology & Metabolism 82 (10), 3293-3297, 1997 | 197 | 1997 |
Multiplex, fluorescent, solid-phase minisequencing for efficient screening of DNA sequence variation T Pastinen, J Partanen, AC Syvänen Clinical Chemistry 42 (9), 1391-1397, 1996 | 193 | 1996 |
Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study K Kaukinen, M Peräaho, P Collin, J Partanen, N Woolley, T Kaartinen, ... Scandinavian journal of gastroenterology 40 (5), 564-572, 2005 | 177 | 2005 |